The vertebroplasty needles market size has grown rapidly in recent years. It will grow from $1.12 billion in 2025 to $1.26 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to rising incidence of osteoporotic spinal fractures, increased adoption of minimally invasive spinal interventions, growing elderly population, wider availability of fluoroscopy-guided procedures, expansion of hospital-based spine care services.
The vertebroplasty needles market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing focus on outpatient spine procedures, rising demand for advanced kyphoplasty techniques, growing investments in precision surgical instruments, expansion of aging population globally, technological improvements in cement delivery systems. Major trends in the forecast period include increasing adoption of single-use vertebroplasty needles, rising demand for image-guided cement delivery systems, growing preference for minimally invasive spine procedures, expansion of precision-engineered needle designs, enhanced focus on procedural safety and accuracy.
An anticipated rise in spine injuries is expected to drive the growth of the vertebroplasty needles market. Spine injuries encompass damage or trauma to the spinal cord, vertebrae, or surrounding tissues, leading to pain, loss of mobility, or paralysis. Factors contributing to the increase in spine injuries include aging populations, greater participation in sports, and the prevalence of motor vehicle accidents. Vertebroplasty needles play a vital role in stabilizing spine injuries by precisely injecting bone cement into fractured vertebrae to alleviate pain and restore vertebral strength. For example, the Spinal Injuries Association reported in May 2024 that the UK saw around 4,400 new cases of spinal cord injury annually, equating to one person becoming paralyzed every two hours and resulting in an estimated total prevalence of 105,000 spinal cord injuries in 2024. Therefore, the rising incidence of spine injuries is fueling the vertebroplasty needles market.
The increasing healthcare expenditure is expected to drive the growth of the vertebroplasty needles market in the coming years. Healthcare expenditure encompasses the total financial resources spent by individuals, organizations, or governments on the prevention, treatment, and management of health conditions. Spending in healthcare is rising due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come with higher costs, contributing to overall increased healthcare spending. Higher healthcare expenditure is promoting the adoption of advanced minimally invasive procedures, supporting greater demand for vertebroplasty needles used in spinal fracture treatments. For example, in December 2024, the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, reported that U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, the rising healthcare expenditure is driving the growth of the vertebroplasty needles market.
The increasing geriatric population is expected to drive the growth of the vertebroplasty needles market in the coming years. The geriatric population includes individuals aged 65 and older, who often experience various health, social, and functional changes associated with aging. This population is expanding primarily due to longer life expectancy, as improvements in healthcare and living conditions allow people to live longer. Vertebroplasty needles aid the geriatric population by enabling minimally invasive procedures that stabilize osteoporotic vertebral fractures, alleviate pain, and improve mobility, thereby enhancing the quality of life for elderly patients. For example, in July 2024, the UK Parliament's House of Commons Library, a UK-based government body, reported that in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This figure is projected to reach 22.1 million by 2072, accounting for 27% of the population. Consequently, the growing geriatric population is fueling growth in the vertebroplasty needles market.
Major companies operating in the vertebroplasty needles market are Medtronic plc, Stryker Corporation, DePuy Synthes Inc., Cook Medical LLC, Merit Medical Systems Inc., Globus Medical Inc., Argon Medical Devices Inc., OptiMed GmbH, Tecres S.p.A, Zavation Medical Products LLC, Auxein Medical Pvt Ltd, Captiva Spine Inc., Laurane Medical LLC, Osseon Technologies, Adroit Manufacturing Co., Surtech Medical Inc., TAEYEON Medical Co. Ltd., Teknimed S A SP, Becton Dickinson and Company, BIOPSYBELL S.R.L.
North America was the largest region in the vertebroplasty needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vertebroplasty needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the vertebroplasty needles market by increasing costs of imported medical-grade stainless steel, precision tubing, imaging-compatible coatings, and sterilization services used in needle manufacturing. Spine care providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border sourcing of high-precision components, while Asia-Pacific faces cost pressure on export-oriented production. These tariffs are contributing to higher device pricing and procurement delays for hospitals. However, they are also encouraging domestic manufacturing, regional supply chain localization, and investment in automated needle production technologies to improve long-term cost efficiency.
The vertebroplasty needles market research report is one of a series of new reports that provides vertebroplasty needles market statistics, including vertebroplasty needles industry global market size, regional shares, competitors with a vertebroplasty needles market share, detailed vertebroplasty needles market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty needles industry. This vertebroplasty needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A vertebroplasty needle is a specialized medical instrument used in the minimally invasive surgical procedure known as vertebroplasty. This procedure is typically performed to treat compression fractures in the spine, often caused by osteoporosis or trauma. The needle is used to inject bone cement (usually a type of acrylic resin) directly into the fractured vertebra under imaging guidance, such as fluoroscopy or a computed tomography (CT) scan, to stabilize the bone and relieve pain. It is designed to be precise and minimally traumatic to surrounding tissues during the cement injection process.
The main types of vertebroplasty needles are 2.5x100, 2.5x130, 3.2x100, and 3.2x130. A 2.5x100 vertebroplasty needle refers to a specific type of medical instrument used in vertebroplasty procedures. It encompasses various product types, such as bone cement needles and aspiration needles, for different procedure types, including percutaneous vertebroplasty and kyphoplasty. These needles can be distributed through hospital pharmacies, private clinics, retail pharmacies, drug stores, and e-commerce platforms.
The vertebroplasty needles market consists of sales of bone cement, cannulas and trocars, injection systems, accessories, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vertebroplasty needles market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing focus on outpatient spine procedures, rising demand for advanced kyphoplasty techniques, growing investments in precision surgical instruments, expansion of aging population globally, technological improvements in cement delivery systems. Major trends in the forecast period include increasing adoption of single-use vertebroplasty needles, rising demand for image-guided cement delivery systems, growing preference for minimally invasive spine procedures, expansion of precision-engineered needle designs, enhanced focus on procedural safety and accuracy.
An anticipated rise in spine injuries is expected to drive the growth of the vertebroplasty needles market. Spine injuries encompass damage or trauma to the spinal cord, vertebrae, or surrounding tissues, leading to pain, loss of mobility, or paralysis. Factors contributing to the increase in spine injuries include aging populations, greater participation in sports, and the prevalence of motor vehicle accidents. Vertebroplasty needles play a vital role in stabilizing spine injuries by precisely injecting bone cement into fractured vertebrae to alleviate pain and restore vertebral strength. For example, the Spinal Injuries Association reported in May 2024 that the UK saw around 4,400 new cases of spinal cord injury annually, equating to one person becoming paralyzed every two hours and resulting in an estimated total prevalence of 105,000 spinal cord injuries in 2024. Therefore, the rising incidence of spine injuries is fueling the vertebroplasty needles market.
The increasing healthcare expenditure is expected to drive the growth of the vertebroplasty needles market in the coming years. Healthcare expenditure encompasses the total financial resources spent by individuals, organizations, or governments on the prevention, treatment, and management of health conditions. Spending in healthcare is rising due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come with higher costs, contributing to overall increased healthcare spending. Higher healthcare expenditure is promoting the adoption of advanced minimally invasive procedures, supporting greater demand for vertebroplasty needles used in spinal fracture treatments. For example, in December 2024, the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, reported that U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, the rising healthcare expenditure is driving the growth of the vertebroplasty needles market.
The increasing geriatric population is expected to drive the growth of the vertebroplasty needles market in the coming years. The geriatric population includes individuals aged 65 and older, who often experience various health, social, and functional changes associated with aging. This population is expanding primarily due to longer life expectancy, as improvements in healthcare and living conditions allow people to live longer. Vertebroplasty needles aid the geriatric population by enabling minimally invasive procedures that stabilize osteoporotic vertebral fractures, alleviate pain, and improve mobility, thereby enhancing the quality of life for elderly patients. For example, in July 2024, the UK Parliament's House of Commons Library, a UK-based government body, reported that in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This figure is projected to reach 22.1 million by 2072, accounting for 27% of the population. Consequently, the growing geriatric population is fueling growth in the vertebroplasty needles market.
Major companies operating in the vertebroplasty needles market are Medtronic plc, Stryker Corporation, DePuy Synthes Inc., Cook Medical LLC, Merit Medical Systems Inc., Globus Medical Inc., Argon Medical Devices Inc., OptiMed GmbH, Tecres S.p.A, Zavation Medical Products LLC, Auxein Medical Pvt Ltd, Captiva Spine Inc., Laurane Medical LLC, Osseon Technologies, Adroit Manufacturing Co., Surtech Medical Inc., TAEYEON Medical Co. Ltd., Teknimed S A SP, Becton Dickinson and Company, BIOPSYBELL S.R.L.
North America was the largest region in the vertebroplasty needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vertebroplasty needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the vertebroplasty needles market by increasing costs of imported medical-grade stainless steel, precision tubing, imaging-compatible coatings, and sterilization services used in needle manufacturing. Spine care providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border sourcing of high-precision components, while Asia-Pacific faces cost pressure on export-oriented production. These tariffs are contributing to higher device pricing and procurement delays for hospitals. However, they are also encouraging domestic manufacturing, regional supply chain localization, and investment in automated needle production technologies to improve long-term cost efficiency.
The vertebroplasty needles market research report is one of a series of new reports that provides vertebroplasty needles market statistics, including vertebroplasty needles industry global market size, regional shares, competitors with a vertebroplasty needles market share, detailed vertebroplasty needles market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty needles industry. This vertebroplasty needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A vertebroplasty needle is a specialized medical instrument used in the minimally invasive surgical procedure known as vertebroplasty. This procedure is typically performed to treat compression fractures in the spine, often caused by osteoporosis or trauma. The needle is used to inject bone cement (usually a type of acrylic resin) directly into the fractured vertebra under imaging guidance, such as fluoroscopy or a computed tomography (CT) scan, to stabilize the bone and relieve pain. It is designed to be precise and minimally traumatic to surrounding tissues during the cement injection process.
The main types of vertebroplasty needles are 2.5x100, 2.5x130, 3.2x100, and 3.2x130. A 2.5x100 vertebroplasty needle refers to a specific type of medical instrument used in vertebroplasty procedures. It encompasses various product types, such as bone cement needles and aspiration needles, for different procedure types, including percutaneous vertebroplasty and kyphoplasty. These needles can be distributed through hospital pharmacies, private clinics, retail pharmacies, drug stores, and e-commerce platforms.
The vertebroplasty needles market consists of sales of bone cement, cannulas and trocars, injection systems, accessories, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vertebroplasty Needles Market Characteristics
3. Vertebroplasty Needles Market Supply Chain Analysis
4. Global Vertebroplasty Needles Market Trends and Strategies
5. Vertebroplasty Needles Market Analysis of End Use Industries
7. Global Vertebroplasty Needles Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vertebroplasty Needles Total Addressable Market (TAM) Analysis for the Market
9. Vertebroplasty Needles Market Segmentation
10. Vertebroplasty Needles Market Regional and Country Analysis
11. Asia-Pacific Vertebroplasty Needles Market
12. China Vertebroplasty Needles Market
13. India Vertebroplasty Needles Market
14. Japan Vertebroplasty Needles Market
15. Australia Vertebroplasty Needles Market
16. Indonesia Vertebroplasty Needles Market
17. South Korea Vertebroplasty Needles Market
18. Taiwan Vertebroplasty Needles Market
19. South East Asia Vertebroplasty Needles Market
20. Western Europe Vertebroplasty Needles Market
21. UK Vertebroplasty Needles Market
22. Germany Vertebroplasty Needles Market
23. France Vertebroplasty Needles Market
24. Italy Vertebroplasty Needles Market
25. Spain Vertebroplasty Needles Market
26. Eastern Europe Vertebroplasty Needles Market
27. Russia Vertebroplasty Needles Market
28. North America Vertebroplasty Needles Market
29. USA Vertebroplasty Needles Market
30. Canada Vertebroplasty Needles Market
31. South America Vertebroplasty Needles Market
32. Brazil Vertebroplasty Needles Market
33. Middle East Vertebroplasty Needles Market
34. Africa Vertebroplasty Needles Market
36. Vertebroplasty Needles Market Competitive Landscape and Company Profiles
37. Vertebroplasty Needles Market Other Major and Innovative Companies
40. Vertebroplasty Needles Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vertebroplasty Needles Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vertebroplasty needles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vertebroplasty needles? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vertebroplasty needles market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Bone Cement Needles; Aspiration Needles2) By Needle Size: 2.5x100; 2.5x130; 3.2x100; 3.2x130
3) By Procedure Type: Percutaneous Vertebroplasty; Kyphoplasty
Subsegments:
1) By Bone Cement Needles: Straight Bone Cement Needles; Curved Bone Cement Needles2) By Aspiration Needles: Small Gauge Aspiration Needles; Medium-Gauge Aspiration Needles; Large-Gauge Aspiration Needles
Companies Mentioned: Medtronic plc; Stryker Corporation; DePuy Synthes Inc.; Cook Medical LLC; Merit Medical Systems Inc.; Globus Medical Inc.; Argon Medical Devices Inc.; OptiMed GmbH; Tecres S.p.A; Zavation Medical Products LLC; Auxein Medical Pvt Ltd; Captiva Spine Inc.; Laurane Medical LLC; Osseon Technologies; Adroit Manufacturing Co.; Surtech Medical Inc.; TAEYEON Medical Co. Ltd.; Teknimed S A SP; Becton Dickinson and Company; BIOPSYBELL S.R.L.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vertebroplasty Needles market report include:- Medtronic plc
- Stryker Corporation
- DePuy Synthes Inc.
- Cook Medical LLC
- Merit Medical Systems Inc.
- Globus Medical Inc.
- Argon Medical Devices Inc.
- OptiMed GmbH
- Tecres S.p.A
- Zavation Medical Products LLC
- Auxein Medical Pvt Ltd
- Captiva Spine Inc.
- Laurane Medical LLC
- Osseon Technologies
- Adroit Manufacturing Co.
- Surtech Medical Inc.
- TAEYEON Medical Co. Ltd.
- Teknimed S A SP
- Becton Dickinson and Company
- BIOPSYBELL S.R.L.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.26 Billion |
| Forecasted Market Value ( USD | $ 1.95 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
